Experienced in Primary Familial Brain Calcification

Pierre C. Krystkowiak

Amiens, FR 
Experienced in Primary Familial Brain Calcification
Amiens, FR 
OverviewLocationsClinical Research

Overview

Pierre Krystkowiak practices in Amiens, France. Mr. Krystkowiak is rated as an Experienced expert by MediFind in the treatment of Primary Familial Brain Calcification. His top areas of expertise are Movement Disorders, Myoclonus-Dystonia, Parkinson's Disease, Huntington Disease, and Deep Brain Stimulation.

His clinical research consists of co-authoring 52 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Primary Familial Brain Calcification.

Gender
Male

Locations

Amiens, France
Other Locations
Poitiers, France
Equipe 01-Neuropsychologie Interventionnelle L'Institut Mondor De Recherches Biomédicales, Université Paris Est Créteil, UMR 1239, CIC 1413, CIC 1402, CNRS UMR 7104, CIC 1414, CHU De Caen, Caen, France
Marseille, France
Rouen, France
Lille, 59037, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomized, Controlled, Open-label Study Evaluating the Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis
Randomized, Controlled, Open-label Study Evaluating the Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Combination product
Study Drug: Extracorporeal Photopheresis
Study Phase: Phase 1/Phase 2
Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Enrollment Status: Completed
Publish Date: January 01, 2025
Intervention Type: Drug, Procedure, Behavioral
Study Drug: Pimavanserin
Study Phase: Phase 2
Predictive Factors for Therapeutic Response of Subthalamic Stimulation on Quality of Live in Parkinson's Disease
Predictive Factors for Therapeutic Response of Subthalamic Stimulation on Quality of Live in Parkinson's Disease
Enrollment Status: Active_not_recruiting
Publish Date: November 07, 2022
Intervention Type: Other
Study of Efficacy and Acceptability of Tetrabenazine in the Late Dyskinetic Syndrome With Neuroleptics: A Randomized, Parallel Group, Double-blind Placebo Controlled Multicentre Trial
Study of Efficacy and Acceptability of Tetrabenazine in the Late Dyskinetic Syndrome With Neuroleptics: A Randomized, Parallel Group, Double-blind Placebo Controlled Multicentre Trial
Enrollment Status: Completed
Publish Date: September 12, 2017
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

52 Total Publications

Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD).
Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD).
Journal: Parkinsonism & related disorders
Published: March 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Krystkowiak's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile